Last reviewed · How we verify
amoxicillin and clarithromycin
amoxicillin and clarithromycin is a Small molecule drug developed by Livzon Pharmaceutical Group Inc.. It is currently FDA-approved.
At a glance
| Generic name | amoxicillin and clarithromycin |
|---|---|
| Sponsor | Livzon Pharmaceutical Group Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Diarrhea
- Dysgeusia
- Vulvovaginal candidiasis
- Headache
- Abdominal pain
- Hypertension
- Nasopharyngitis
- Nausea
- Vomiting
- Dyspepsia
- Flatulence
- Constipation
Serious adverse events
- QT prolongation
- Pneumonia
- Drug hypersensitivity
- Duodenal ulcer
- Gastric ulcer
- Gastroesophageal reflux disease
- Anemia
- Leukopenia
- Neutropenia
- Tachycardia
Key clinical trials
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial (PHASE2)
- Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial (NA)
- Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study
- Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1 (PHASE4)
- Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy (PHASE4)
- The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change
- Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection (PHASE2)
- Fecal Molecular Susceptibility-guided Hp First-line Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- amoxicillin and clarithromycin CI brief — competitive landscape report
- amoxicillin and clarithromycin updates RSS · CI watch RSS
- Livzon Pharmaceutical Group Inc. portfolio CI
Frequently asked questions about amoxicillin and clarithromycin
What is amoxicillin and clarithromycin?
amoxicillin and clarithromycin is a Small molecule drug developed by Livzon Pharmaceutical Group Inc..
Who makes amoxicillin and clarithromycin?
amoxicillin and clarithromycin is developed and marketed by Livzon Pharmaceutical Group Inc. (see full Livzon Pharmaceutical Group Inc. pipeline at /company/livzon-pharmaceutical-group-inc).
What development phase is amoxicillin and clarithromycin in?
amoxicillin and clarithromycin is FDA-approved (marketed).
What are the side effects of amoxicillin and clarithromycin?
Common side effects of amoxicillin and clarithromycin include Diarrhea, Dysgeusia, Vulvovaginal candidiasis, Headache, Abdominal pain, Hypertension. Serious adverse events: QT prolongation, Pneumonia, Drug hypersensitivity, Duodenal ulcer.
Related
- Manufacturer: Livzon Pharmaceutical Group Inc. — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing